Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fagin

Showing results (121-130 of 261) with videos related to

Pageof 27
Sort By:
The Journal of Clinical Investigation|September 18, 1997
Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic miceJ Wang, W Niu, Y Nikiforov, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2013
Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the diseaseIñigo Landa, Ian Ganly, Timothy A Chan, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2015
Response to: Letter to the Editor Regarding the Article "Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma"Laura Boucai, Laura Y Wang, Andrew W Smith, et al.
Histopathology|March 26, 2024
Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patientsRonald Ghossein, Nora Katabi, Snjezana Dogan, et al.
Circulation Research|April 1, 1996
Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitroA Hultgårdh-Nilsson, B Cercek, J W Wang, et al.
Cancer Research|June 4, 2008
RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFRMichelle Croyle, Nagako Akeno, Jeffrey A Knauf, et al.
Endocrinology|October 29, 2005
BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesisNorisato Mitsutake, Makoto Miyagishi, Shin Mitsutake, et al.
Human Pathology|November 17, 2009
Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular studyMichael Rivera, Julio Ricarte-Filho, Snehal Patel, et al.
American Journal of Human Genetics|July 31, 1998
From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridizationX Chen, J A Knauf, R Gonsky, et al.
Cancer Research|July 5, 2006
Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodelingCleo Mesa, Mana Mirza, Norisato Mitsutake, et al.
Pageof 27

Showing results (121-130 of 261) with videos related to

Sort By:
Pageof 27
The Journal of Clinical Investigation|September 18, 1997
Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic miceJ Wang, W Niu, Y Nikiforov, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2013
Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the diseaseIñigo Landa, Ian Ganly, Timothy A Chan, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2015
Response to: Letter to the Editor Regarding the Article "Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma"Laura Boucai, Laura Y Wang, Andrew W Smith, et al.
Histopathology|March 26, 2024
Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patientsRonald Ghossein, Nora Katabi, Snjezana Dogan, et al.
Circulation Research|April 1, 1996
Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitroA Hultgårdh-Nilsson, B Cercek, J W Wang, et al.
Cancer Research|June 4, 2008
RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFRMichelle Croyle, Nagako Akeno, Jeffrey A Knauf, et al.
Endocrinology|October 29, 2005
BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesisNorisato Mitsutake, Makoto Miyagishi, Shin Mitsutake, et al.
Human Pathology|November 17, 2009
Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular studyMichael Rivera, Julio Ricarte-Filho, Snehal Patel, et al.
American Journal of Human Genetics|July 31, 1998
From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridizationX Chen, J A Knauf, R Gonsky, et al.
Cancer Research|July 5, 2006
Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodelingCleo Mesa, Mana Mirza, Norisato Mitsutake, et al.
Pageof 27